Palantir’s, Valuation

Palantir’s Valuation Reckoning: Record Quarter and Zeta Deal Fail to Halt Slide as Europe Turns Away

Published on 06/25/2026 at 19:24 | Redaktion boerse-global.de

Despite record revenue and raised guidance, Palantir's stock nears 52-week low as valuation above 121x P/E and European regulatory backlash weigh on sentiment.

Palantir Q1 Revenue Soars 85%, Stock Drops 48% on Valuation and EU Risks
Palantir’s Valuation Reckoning: Record Quarter and Zeta Deal Fail to Halt Slide as Europe Turns Away Illustration mit AI erstellt übermittelt durch boerse-global.de

The numbers tell one story. The stock price tells quite another. Palantir reported a blowout first quarter, raised its full-year guidance, and sealed a strategic partnership with Zeta Global that cements its shift toward commercial AI infrastructure. Yet the market keeps selling: shares touched €94.18 on Thursday, a loss of nearly 6%, and now sit less than 1% above their 52-week low of €93.53. Since the start of the year, the equity has surrendered roughly 34%, and from the November 2025 all-time high of €179.98, the decline approaches 48%.

The disconnect isn’t about operational performance, which was objectively robust. Revenue vaulted 85% to $1.63 billion, with the US segment leading the charge at a 104% surge to $1.28 billion. GAAP net income reached $871 million, while free cash flow hit $925 million. Management lifted its 2026 revenue forecast to approximately $7.66 billion and guided for adjusted free cash flow of $4.2 billion to $4.4 billion. On the deal front, Palantir closed 206 contracts worth at least $1 million each during the quarter, 47 of them exceeding $10 million. Total contract value came in at $2.41 billion, up 61% year over year.

Yet the market is fixated on something else: a reckoning with valuation and a growing European backlash. The stock’s trailing twelve-month price-to-earnings ratio still stands above 121, making it a prime target when risk appetite fades. The relative strength index has dropped to 27, a deeply oversold reading, and the share price now trades roughly 20% below its 50-day moving average and more than 30% below its 200-day counterpart.

The selloff is not isolated. Earlier in the week, a broader rout hit AI stocks after doubts emerged about the sustainability of the capital spending plans underpinning the boom. South Korea’s KOSPI slid nearly 10%, and the Nasdaq closed down 2.2%. For Palantir, which is essentially a leveraged bet on enterprise AI adoption, the sector-wide de-risking has been especially punishing.

Should investors sell immediately? Or is it worth buying Palantir?

But beneath the technical damage lies a structural problem that no amount of US commercial success can easily fix. In Europe, Palantir is losing ground on multiple fronts. In June 2026, the Zurich Commercial Court threw out most of the lawsuit the company had filed against the Swiss magazine Republik — a legal defeat that underscores a hostile regulatory climate. France has already replaced Palantir’s platform in parts of its intelligence services with domestic alternatives, and German authorities are excluding the firm from certain public tenders. The recently enacted EU anti-SLAPP directive adds further pressure on companies that use litigation to silence critical reporting. The phrase “technology sovereignty” has become procurement policy from Paris to Berlin, giving local vendors an intrinsic edge.

Meanwhile, the company’s talent pool is leaking. Former executives have founded their own startups and are now chasing the same lucrative government contracts Palantir once owned, including within the UK’s National Health Service. The specialized expertise that once made Palantir indispensable is no longer exclusive, as its own alumni weaponize inside knowledge to build niche competitors.

To offset these headwinds, Palantir is leaning hard into the US commercial market. The partnership with Zeta Global is emblematic: Palantir is embedding its Foundry platform and AI Platform into marketing-technology infrastructure, moving away from its defense-contractor roots and toward a role as the data backbone for private-sector enterprises. Analysts see this as a genuine step from experimental AI pilots toward scalable, value-generating ecosystems.

Palantir at a turning point? This analysis reveals what investors need to know now.

The current analyst price target of €161.30 captures the ambivalence — robust US growth weighed against European erosion, commercial expansion pitted against political exclusion. The stock is not a vote of confidence; it’s a wager on whether America’s commercial engine can outrun the retreat unfolding in Zürich, Paris, and Berlin. The next quarter’s numbers, expected in August, will determine whether that wager is still rational.

Ad

Palantir Stock: New Analysis - 25 June

Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Palantir analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US69608A1088 | PALANTIR’S | boerse | 69626404 |